SCHEMBL6174785

SCHEMBL6174785

CC1(Cc2ccnc(-c3cccc(Cl)c3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 1/20 0.41
NTRK1 P04629 1/20 0.37
ABL1 P00519 5/20 0.36
AR P10275 3/20 0.36
HTT P42858 1/20 0.35
BCR P11274 4/20 0.35
GRIN2B Q13224 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
FNTA P49354 1/20 0.34
PGGT1B P53609 1/20 0.34
CCR6 P51684 4/20 0.34
KCNH2 Q12809 2/20 0.34
SCN9A Q15858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174845 0.90 NTRK1 (0.38) ITGALNTRK1AR
SCHEMBL6174753 0.86 MAT2A (0.43) ITGALARMAPT
SCHEMBL6171101 0.86 TRPA1 (0.43) ITGALARMAPK1SCN9A
SCHEMBL6177662 0.86 IGF1R (0.40) ITGALARHTTMAPT
SCHEMBL6174653 0.85 ITGAL (0.39) ITGALNTRK1ARKCNH2SCN9A
SCHEMBL6175298 0.83 GRM5 (0.45) NTRK1ABL1
SCHEMBL2938922 0.81 IGF1R (0.54) NTRK1
SCHEMBL6175657 0.81 IGF1R (0.45) ITGALNTRK1ARGRIN2BKCNH2
SCHEMBL6176754 0.81 ITGAL (0.44) ITGALNTRK1ARSCN9A
SCHEMBL6173435 0.81 IGF1R (0.45) ITGALNTRK1ABL1ARSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed